BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12182838)

  • 1. Heterologous expression, purification, and enzymatic activity of Mycobacterium tuberculosis NAD(+) synthetase.
    Bellinzoni M; De Rossi E; Branzoni M; Milano A; Peverali FA; Rizzi M; Riccardi G
    Protein Expr Purif; 2002 Aug; 25(3):547-57. PubMed ID: 12182838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain.
    Bellinzoni M; Buroni S; Pasca MR; Guglierame P; Arcesi F; De Rossi E; Riccardi G
    Res Microbiol; 2005 Mar; 156(2):173-7. PubMed ID: 15748981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics and structural features of dimeric glutamine-dependent bacterial NAD
    Santos ARS; Gerhardt ECM; Moure VR; Pedrosa FO; Souza EM; Diamanti R; Högbom M; Huergo LF
    J Biol Chem; 2018 May; 293(19):7397-7407. PubMed ID: 29581233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro characterization of the NAD+ synthetase NadE1 from Herbaspirillum seropedicae.
    Laskoski K; Santos AR; Bonatto AC; Pedrosa FO; Souza EM; Huergo LF
    Arch Microbiol; 2016 May; 198(4):307-13. PubMed ID: 26802007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and bactericidal effects of targeted suppression of NadD and NadE enzymes in mycobacteria.
    Rodionova IA; Schuster BM; Guinn KM; Sorci L; Scott DA; Li X; Kheterpal I; Shoen C; Cynamon M; Locher C; Rubin EJ; Osterman AL
    mBio; 2014 Feb; 5(1):. PubMed ID: 24549842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD
    Wang X; Ahn YM; Lentscher AG; Lister JS; Brothers RC; Kneen MM; Gerratana B; Boshoff HI; Dowd CS
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4426-4430. PubMed ID: 28827112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MTCY428.08 gene of Mycobacterium tuberculosis codes for NAD+ synthetase.
    Cantoni R; Branzoni M; Labò M; Rizzi M; Riccardi G
    J Bacteriol; 1998 Jun; 180(12):3218-21. PubMed ID: 9620974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning, expression, purification, crystallization and preliminary X-ray diffraction studies of NAD synthetase from methicillin-resistant Staphylococcus aureus.
    Arbade GK; Srivastava SK
    Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):763-9. PubMed ID: 26057809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ancestral glutamine-dependent NAD(+) synthetase revealed by poor kinetic synergism.
    Resto M; Yaffe J; Gerratana B
    Biochim Biophys Acta; 2009 Nov; 1794(11):1648-53. PubMed ID: 19647806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different ways to transport ammonia in human and Mycobacterium tuberculosis NAD
    Chuenchor W; Doukov TI; Chang KT; Resto M; Yun CS; Gerratana B
    Nat Commun; 2020 Jan; 11(1):16. PubMed ID: 31911602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural adaptation of an interacting non-native C-terminal helical extension revealed in the crystal structure of NAD+ synthetase from Bacillus anthracis.
    McDonald HM; Pruett PS; Deivanayagam C; Protasevich II; Carson WM; DeLucas LJ; Brouillette WJ; Brouillette CG
    Acta Crystallogr D Biol Crystallogr; 2007 Aug; 63(Pt 8):891-905. PubMed ID: 17642516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable ammonia-specific NAD synthetase from Bacillus stearothermophilus: purification, characterization, gene cloning, and applications.
    Yamaguchi F; Koga S; Yoshioka I; Takahashi M; Sakuraba H; Ohshima T
    Biosci Biotechnol Biochem; 2002 Oct; 66(10):2052-9. PubMed ID: 12450114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of active site coupling in glutamine-dependent NAD(+) synthetase.
    LaRonde-LeBlanc N; Resto M; Gerratana B
    Nat Struct Mol Biol; 2009 Apr; 16(4):421-9. PubMed ID: 19270703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural study of Escherichia coli NAD synthetase: overexpression, purification, crystallization, and preliminary crystallographic analysis.
    Ozment C; Barchue J; DeLucas LJ; Chattopadhyay D
    J Struct Biol; 1999 Oct; 127(3):279-82. PubMed ID: 10544053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallization and X-ray analysis of NH3-dependent NAD+ synthetase from Helicobacter pylori.
    Kang GB; Kim YS; Im YJ; Rho SH; Eom SH
    Protein Pept Lett; 2003 Aug; 10(4):418-21. PubMed ID: 14529496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative genomics of NAD(P) biosynthesis and novel antibiotic drug targets.
    Bi J; Wang H; Xie J
    J Cell Physiol; 2011 Feb; 226(2):331-40. PubMed ID: 20857400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular identification of human glutamine- and ammonia-dependent NAD synthetases. Carbon-nitrogen hydrolase domain confers glutamine dependency.
    Hara N; Yamada K; Terashima M; Osago H; Shimoyama M; Tsuchiya M
    J Biol Chem; 2003 Mar; 278(13):10914-21. PubMed ID: 12547821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Mycobacterium tuberculosis NAD kinase: functional analysis of the full-length enzyme by site-directed mutagenesis.
    Raffaelli N; Finaurini L; Mazzola F; Pucci L; Sorci L; Amici A; Magni G
    Biochemistry; 2004 Jun; 43(23):7610-7. PubMed ID: 15182203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning, overexpression, and purification of novobiocic acid synthetase from Streptomyces spheroides NCIMB 11891.
    Steffensky M; Li SM; Heide L
    J Biol Chem; 2000 Jul; 275(28):21754-60. PubMed ID: 10801869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallographic and molecular dynamics simulation analysis of NAD synthetase from methicillin resistant Staphylococcus aureus (MRSA).
    Sultana KN; Kuldeep J; Siddiqi MI; Srivastava SK
    Int J Biol Macromol; 2020 Dec; 165(Pt B):2349-2362. PubMed ID: 33098904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.